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ORIGINAL ARTICLE
Dry needling reduces pain in Sanglah General Hospital 
Denpasar workers with myofascial pain syndrome in the 
upper trapezius muscle 
Thomas Eko Purwata, I Made Oka Adnyana, I Putu Eka Widyadharma, Widyawati Suhendro
BACKGROUND  
Myalgia is a common complaint in the general population, but it is 
underappreciated and often undertreated. Myofascial pain 
syndrome is a form of myalgia that is characterized by local regions 
of muscle hardness. The main components of this syndrome are the 
trigger points that are composed of taut bands. Various invasive and 
non-invasive procedures are available to inactivate myofascial trigger 
points. Dry needling involves inserting a filiform needle directly into 
a trigger point without injection of material. Dry needling is a 
treatment modality that is minimally invasive, cheap, easy to learn, 
and carries a low risk for reducing pain.  
OBJECTIVE 
The aim of this study was to test the hypothesis that dry needling 
could reduce pain in subjects with myofascial pain syndrome in the 
upper trapezius muscle on Sanglah Hospital’s workers. 
METHOD  
Twenty-six subjects with myofascial pain syndrome in the upper 
trapezius muscle were randomly divided into two groups: 13 subjects 
in the control group received acetaminophen, and 13 subjects in the 
dry needling group received dry needling and acetaminophen. The 
numeric rating scale was assessed before, 1 hour, 24 hours, and 7 
days after the treatment. Side effects of dry needling were evaluated 
every day for 7 days follow-up. The total amount of acetaminophen 
was assessed at last day follow up. 
RESULTS  
At baseline, the numeric rating scale was same in control versus dry 
needling group. Reduction in all numeric rating scale at 1 hour, 24 
hours, and 7 days after dry needling was significant (p<0.05).  
CONCLUSION  
Dry needling could reduce pain and oral analgesic consumption in 
subjects with myofascial pain syndrome in the upper trapezius 
muscle. There were no side effects of dry needling reported on this 
study. 
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BACKGROUND 
Myalgia is a common widespread problem, but 
is often ignored and therapy,when applied is 
often inadequate. Myofascial Pain Syndrome 
(MPS) is a form of myalgia with local muscle 
stiffness. The main component in MPS is the 
presence of trigger points that cause pain and 
the appearance of band links. In addition to 
medical therapy, MPS therapy is focused on 
inactivating trigger points. Inactivation of 
trigger points can be in the form of non-
invasive mechanical stimulation and invasive 
actions. Dry needling (DN) is one way to 
inactivate trigger points. DN is an invasive 
procedure using filiform needles without using 
drugs.1-7 
MPS often causes acute and chronic muscle 
pain with diverse manifestations such as 
tension-type headache, shoulder pain, low 
back pain, and other symptoms. Pain in MPS is 
usually blunt and difficult to localize.1-2  
Trigger points are hyper-irritative points 
within the band link of skeletal muscle fibers, 
that produce local ischemia and hypoxia with 
central and peripheral sensitization. There are 
two types of trigger points, active trigger 
points that cause pain even though the 
muscles are resting and latent trigger points 
which are not spontaneous triggers of pain.2-3,6 
Epidemiological studies of MPS are still 
difficult because there is no consensus which 
regulates the diagnostic criteria of this 
syndrome by default. The highest prevalence 
of musculoskeletal pain in the neck area in 
workers is 60-76% with the highest intensity of 
77.3% occurring in the upper trapezius muscle. 
This is due to the high involvement of the 
hands (e.g. typing, raising arms, transporting 
goods), thus increasing muscle demands in the 
surrounding anatomical area. In Indonesia, 
MPS is more prevalent in women at 58.8%, 
work as employees ranks highest at 41.2%, 
with the highest average age of 20-40 years.4,9-
11  
The mechanism for the formation of band links 
is due to muscle trauma as a result of excessive 
use. This triggers the production and release 
of acetylcholine from the motor terminal of 
the neuron, even at rest. Persistent release of 
acetylcholine generates postjunctional 
membrane depolarization of muscle fibers. 
Increased muscle work and demand maintains 
the muscle in a prolonged contraction state. 
This in turn may compromise the vascular 
supply of oxygen and nutrients due to a 
compression effect. This condition, when 
inadequately treated will lead to hypoxia and 
subsequent impairment of the calcium channel 
pump responsible for returning calcium ion 
into the sarcoplasmic reticulum. 
This mechanism then continually triggers both 
the release of Calcium and causes its 
inadequate intake from the sarcoplasmic 
reticulum. This results in shortening of the 
sarcomere. If this phenomenon is prolonged, 
muscle tissue hypoxia will occur followed by 
the release of vasoactive and allogeneic 
substances such as CGRP, Substance P, 
bradykinin, cytokines, and protons. Local pain, 
peripheral and central sensitization will occur 
as a consequence of the release of these 
substances. This cycle will continue if not 
corrected.1,2,12-15  
The principle of managing MPS is to deactivate 
trigger points and maintain normal body 
biomechanics. Therapy modalities focus on 
trigger points, both through pharmacological 
and non-pharmacological therapy aimed at 
reducing inflammation and sensitization which 
are the sources of the onset of pain. Giving 
analgesics can reduce pain significantly, but 
does not restore function. Trigger point 
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manipulation is needed. This can be in the form 
of both invasive and non-invasive action. 
Examples of the latter are massage, electrical 
stimulation, and magnetic therapy. Invasive 
therapy is often done as an injection of local 
trigger points with certain substances; it can 
also be done using DN. 2-4,6,7  
DN is an attempt to activate trigger points 
using thin filiform needles to penetrate the 
skin and stimulate the areas that underlie the 
trigger points, viz., muscles, and connective 
tissue. It is done for the management of pain 
and the disruption of muscle spasm. Other 
advantages of DN are that it is cheap and easy 
to carry out with minimal side effects. 
METHODS 
This study used an experimental pre-test and 
post-test control group design with research 
subjects divided into two groups, namely the 
treatment group (analgesic and DN) and the 
control group (analgesic). The study was 
conducted on workers in the Sanglah General 
Hospital in Denpasar from September to 
October 2018. This study was declared 
ethically feasible by the Research Ethics 
Commission of the Faculty of Medicine, 
Udayana University/Sanglah Hospital 
Denpasar with no: 
1602/UN14.2.2/PD/KEP/2018 
The inclusion criteria in this study were 
workers aged 20-50 years who experienced 
pain in the upper trapezius muscle with a 
numeric rating scale (NRS) ≥ 4  together with 
trigger points located on examination in the 
upper trapezius muscle. The subjects were 
cooperative and willing to be included in the 
study and signed a document confirming 
informed consent. Exclusion criteria in this 
study were subjects with a history of 
immunodeficiency (malignancy, HIV infection, 
and diabetes mellitus), a history of blood 
clotting disorders, the use of drugs that 
interfere with blood hemostasis, infection and 
insertion wounds, needle phobia, allergy to 
acetaminophen and the ingestion of 
analgesics and muscle relaxants in the 
previous 24 hours. Subjects who met the 
eligibility criteria were divided into two groups 
using a coin toss as a simple randomization 
technique. The drop out criteria in this study 
were subjects who did not collect the 
questionnaires, consumed analgesics other 
than acetaminophen and muscle relaxants 
during the observation period, underwent 
non-invasive and other invasive therapies, 
together with those who were unwilling to 
continue therapy.  
Calculation of sample size used the Pocock 
formula with an alpha of 0.05 obtained by the 
18 total samples needed. To avoid a dropout of 
15%, a sample size of at least 22 subjects was 
necessary. 
Trigger points were obtained by palpation of 
the upper trapezius muscle and the location of 
a band link and pain response from the subject. 
DN procedures were carried out by one person 
who was competent in carrying them out. This 
study used a Huanqiu brand needle with a 
diameter of 0.25 mm and a length of 40 mm, 
the needle was inserted into the trigger point 
of the upper trapezius muscle until a local 
twitch response appeared. It was then 
withdrawn when there were no more visible 
twitch responses from the muscle. The 
procedure was repeated on any other existing 
trigger points. The DN procedure was stopped 
when there was a reduction in the frequency of  
appearance of a local twitch response and 
reduced resistance on palpation. The DN 
procedure was only performed once, i.e. at the 
beginning of the study period for each patient. 
Subjects in both groups were given an 
analgesic (1g of acetaminophen) at the start of 
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the procedure and were then were allowed to 
take it again with a maximum dose of 4 
grams/day. The pain scale was assessed using 
NRS. NRS is a pain measuring system using 
numbers 0-10. NRS was assessed before DN 
was performed, then reassessed 1 hour, 24 
hours, and 7 days after the DN. Subjects were 
followed for 7 days and during the observation 
period were evaluated for the presence of DN 
side effects in the form of bruising, swelling 
and bleeding, together with an assessment of 
the use of acetaminophen. If during the 
observation period, the subjects consumed 
other analgesics and muscle relaxants, 
underwent other non-invasive or invasive 
therapies, or refused to continue therapy, they 
were excluded from the study. 
Data was analyzed using SPSS version 20.0. 
Descriptive data analysis was performed to 
study the distribution of age, gender, type of 
work, and initial NRS value. Normality test was 
based on numerical data using the Shapiro-
Wilk test. Comparison of the mean reduction in 
NRS values before and after treatment in both 
groups was done using the ANOVA test if the 
data was spread normally or the Mann-
Whitney test if the data was spread abnormally 
with a significance level of p<0.05. If drop out 
>15%, the intention to treat analysis was done. 
RESULTS 
There were 26 subjects who met the eligibility 
criteria in this study. The subjects of the study 
were randomized by simple randomization and 
divided into 13 subjects as the treatment 
group (acetaminophen and DN therapy) and 13 
subjects as the control group (acetaminophen 
therapy). The basic criteria of the research 
subject and statistical analysis in the form of 
age, sex, and type of work are presented in 
table 1. Statistically, no variable results were 
found for age, sex, and type of work. 
The effect of acetaminophen and DN 
administration on NRS improvement in labor in 
Sanglah Hospital Denpasar was assessed by 
comparing the difference in NRS reduction 
between the control group and the treatment 
group at 1 hour, 24 hours, and 7 days after 
treatment. The normality test of NRS 
reduction difference data using the Shapiro 
Wilk test showed that the distribution of data 
was not normal, the hypothesis test used was 
the Mann-Whitney test, the level of 
significance was measured by the value p<0.05. 
The difference in NRS at 1 hour, 24 hours, and 
7 days was found to be statistically significant. 
The analysis results are presented in table 2. 
There were significant differences in the total 
and duration of analgesic use during the 7-day 
observation period in both groups. The results 
of the total analysis and duration of analgesic 
use are presented in table 3. 
In the treatment group, evaluation of DN side 
effects, viz., bruising, swelling and bleeding 
was carried out over a 7-day period. No side 
effects were found in any subject in the 
treatment group. 
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Table 1 Basic characteristics 
 
Variables 
Treatment 
(n=13) 
Control 
(n=13) 
P 
Age (year) 48 (23-50) 35 (23-50) 0.054 
Sex 
Men  5 (38.5%) 4 (30.8%) 
0.500 
Women 8 (61.5%) 9 (69.2%) 
Occupation 
Nurse 6 (46.2%) 4 (30.8%) 
0.670 Student 4 (30.8%) 6 (46.2%) 
Others 3 (23.1%) 3 (23.1%) 
 
Table 2 Analysis of NRS reduction differences at 1 hour, 24 hours, and 7 days after treatment 
 Treatment 
(n=13) 
Control 
(n=13) 
p 
1 hour 2 (0-4) 0 (0-1) 0.003* 
24 hour 3 (0-5) 1 (0-4) 0.014* 
7 days 4 (3-7) 3 (1-7) 0.001* 
*statistically significant 
 
Table 3 Total and duration of analgesic use 
 Treatment 
(n=13) 
Control 
(n=13) 
p 
Total analgesic (gram) 2 (0-3) 4 (1.5-21) 0.008* 
Duration (days) 2 (0-5) 5 (2-7) 0.004* 
*statistically significant 
 
DISCUSSION  
The median age of this study is 48 (23-50) in 
the treatment group and 35 (23-50) in the 
control group. This result is not much different 
from the study conducted by Tsai et al. who 
quote an average age of 41.5±10.4 in the 
control group and 46.4±12.2 in the treatment 
group. 17 Research conducted by Tekin et al 
(2013) also found similar results regarding the 
mean ages of that study’s participants; these 
were 42±12 and 42.9±10.9 years in the control 
and treatment groups, respectively.18 
Research conducted by Cerezo-Tellez et al. 
obtained a  mean age of 46±16.2 in the control 
group and 40.1±13.1 in the treatment group.19  
This result is in accordance with previous 
studies which stated that the productive age 
range contains the highest percentage of 
those who experience MPS.  This is due to 
individuals who are more active in using their 
muscles being in the productive age. 
Based on the gender category, this study 
contains 17 female subjects and 9 male 
subjects. This is similar to the research 
conducted by Gerber et al (2015) who quotes 
10 female subjects more than male subjects.20 
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Research conducted by Tekin et al (2013) with 
a total sample of 39 subjects also quotes 31 
more female than male subjects.18 Research 
conducted by Tsai et al (2010) also found that 
there were 21 more female than male 
subjects.17 The results of this study support 
the view that women make more use their 
hands and shoulders in doing work and have 
lower pain thresholds when compared to men. 
The subjects of this study were 10 nurses, 10 
students, and 6 employees in other 
occupations (3 cleaning service employees, 2 
administrative employees, 1 nutrition officer). 
Until this study there have been no studies 
that specify the types of work carried out by 
the subjects. Research conducted by Cerezo-
Tellez et al. looking at the prevalence of MPS, 
divided occupations based on job 
characteristics. Their results showed that most 
MPS sufferers were subjects who worked by 
hand and often raised their hands higher than 
their shoulders by 76.6 %, followed by 72.3% 
of subjects who did repetitive work.9 Research 
conducted by Meulemeester et al. also states 
that someone with long repetitive and static 
work such as employees who work at a 
computer can trigger MPS.21 This is caused by 
a motor unit that works excessively and causes 
changes in muscle morphology, muscle pain, 
and fatigue. 
The effect of DN administration on NRS 
improvement was assessed by comparing the 
median difference in NRS reduction between 
the control and treatment groups at 1 hour, 24 
hours, and 7 days after treatment. In this study, 
the effectiveness of DN addition to NRS 
reduction was statistically significant (p<0.05) 
compared to the use of acetaminophen alone 
at 1 hour, 24 hours, and 7 days after treatment. 
A similar study carried out by Tsai et al. 
compared NRS decrease before and 
immediately after DN and obtained significant 
results.17 Abbaszadeh-Amirdehi et al. also 
conducted a similar study and obtained 
significantly different results when compared 
to the control group (subjects without MPS).22 
Gerber et al. assessed the scale of pain using 
VAS before DN performed 3 times in 3 weeks 
in subjects with bilateral or unilateral upper 
trapezius chronic MPS. There was a significant 
decrease in VAS (p<0.01) after 3 weeks both in 
subjects with bilateral and unilateral MPS. 20 
Longer observations were carried out by 
Cerezo-Tellez et al. by assessing VAS at 30 and 
45 days after DN with results that were 
significant in both observations (p<0.01) 
compared to the control group (which only 
underwent muscle stretching therapy.19  
During the observation period, there were no 
subjects in the treatment group who reported 
any side effects of DN actions in the form of 
bruising, swelling and bleeding. Very little data 
was obtained regarding the side effects of DN 
actions in similar studies. Research conducted 
by Martin-Pintado-Zugasti et al. reported a 
side effect of bleeding in 4 of the total 26 
subjects studied. The absence of side effects in 
this study was due to the fact that the 
operators who carried out DN actions were 
properly trained and competent in their field.23 
This proves that DN is a minimally invasive 
procedure that is easy to perform and has 
minimal side effects. 
The total amount and duration of use of 
analgesic drugs (acetaminophen) during the 7-
day observation period were found to be 
statistically significant (p<0.05). Until now, 
researchers have not found any studies that 
directly compare the addition of DN with the 
use of analgesic drugs. The results of this study 
support that DN actions can reduce the total 
and duration of analgesic use. 
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CONCLUSION  
The results of this study prove that DN is 
effective in reducing the scale of pain in upper 
trapezius muscle MPS; these results are 
consistent with previous similar studies. The 
analgesic effect caused by DN is related to the 
modulation of central and peripheral pain. This 
includes segmental inhibition and release of 
biochemical cascades such as endogenous 
opioids. In addition, this study also shows that 
DN can reduce the use of analgesic drugs in 
upper trapezius muscle MPS without 
significant side effects. 
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